International Journal of Pharmaceutics · 2024 · 45 citations · 31 references
PharmacyBioengineeringPharmaceuticsBioavailabilityDrug DeliveryTransdermal Drug DeliveryBiologic Skin SubstitutesProtein DeliverySkin Barrier FunctionTransdermal Delivery Of PeptidesTransdermal FormulationsTransdermal Patch DesignBovine Serum AlbuminMembrane PermeationPeptide Skin PermeationPermeation StudiesProtein Delivery CarriersTransdermal Delivery SystemsTransdermal Drug Delivery SystemsTransdermal Peptide Formulation
In vitro permeation studies play a crucial role in early formulation optimisation before extensive animal model investigations. Biological membranes are typically used in these studies to mimic human skin conditions accurately. However, when focusing on protein and peptide transdermal delivery, utilising biological membranes can complicate analysis and quantification processes. This study aims to explore Parafilm®M and Strat-M® as alternatives to dermatomed porcine skin for evaluating protein delivery from dissolving microarray patch (MAP) platforms. Initially, various MAPs loaded with different model proteins (ovalbumin, bovine serum albumin and amniotic mesenchymal stem cell metabolite products) were prepared. These dissolving MAPs underwent evaluation for insertion properties and in vitro permeation profiles when combined with different membranes, dermatomed porcine skin, Parafilm®M, and Strat-M®. Insertion profiles indicated that both Parafilm®M and Strat-M® showed comparable insertion depths to dermatomed porcine skin (in range of 360-430 µm), suggesting promise as membrane substitutes for insertion studies. In in vitro permeation studies, synthetic membranes such as Parafilm®M and Strat-M® demonstrated the ability to bypass protein-derived skin interference, providing more reliable results compared to dermatomed neonatal porcine skin. Consequently, these findings present valuable tools for preliminary screening across various MAP formulations, especially in the transdermal delivery of proteins and peptides.
31
Ryan F. Donnelly, Rita Majithiya, Thakur Raghu Raj Singh et al. · Pharmaceutical Research · 2010 · 408 citations · Full text
Ryan F. Donnelly, Martin J. Garland, Desmond I. J. Morrow et al. · Journal of Controlled Release · 2010 · 299 citations
Wim Jiskoot, Theodore W. Randolph, David B. Volkin et al. · Journal of Pharmaceutical Sciences · 2011 · 250 citations